Concepts (186)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Hypertension, Pulmonary | 16 | 2021 | 970 | 4.38 | Why? |
| Pulmonary Artery | 4 | 2019 | 803 | 1.39 | Why? |
| Antifungal Agents | 13 | 2020 | 1828 | 1.34 | Why? |
| Candida albicans | 3 | 2018 | 217 | 1.29 | Why? |
| Candida parapsilosis | 2 | 2018 | 34 | 0.93 | Why? |
| Pulmonary Wedge Pressure | 2 | 2018 | 53 | 0.91 | Why? |
| Candida | 4 | 2019 | 425 | 0.90 | Why? |
| Drug Resistance, Fungal | 6 | 2019 | 191 | 0.88 | Why? |
| Candidemia | 4 | 2019 | 353 | 0.82 | Why? |
| Fluconazole | 2 | 2019 | 145 | 0.81 | Why? |
| Polystyrenes | 1 | 2019 | 98 | 0.73 | Why? |
| Angioplasty, Balloon | 1 | 2018 | 66 | 0.70 | Why? |
| Biofilms | 3 | 2019 | 304 | 0.69 | Why? |
| Pulmonary Veno-Occlusive Disease | 1 | 2017 | 28 | 0.69 | Why? |
| Aneurysm | 1 | 2018 | 117 | 0.68 | Why? |
| Microbiological Techniques | 1 | 2019 | 232 | 0.65 | Why? |
| Cardiac Tamponade | 1 | 2019 | 165 | 0.63 | Why? |
| Pericardial Effusion | 1 | 2019 | 312 | 0.57 | Why? |
| Aspergillus fumigatus | 3 | 2020 | 239 | 0.56 | Why? |
| Aneurysm, Dissecting | 1 | 2019 | 303 | 0.54 | Why? |
| Vascular Resistance | 3 | 2019 | 148 | 0.53 | Why? |
| Familial Primary Pulmonary Hypertension | 3 | 2018 | 68 | 0.52 | Why? |
| Azoles | 2 | 2017 | 185 | 0.48 | Why? |
| DNA | 1 | 2017 | 778 | 0.45 | Why? |
| Pulmonary Embolism | 3 | 2020 | 4775 | 0.44 | Why? |
| Reagent Kits, Diagnostic | 1 | 2020 | 2149 | 0.41 | Why? |
| Candida glabrata | 3 | 2018 | 50 | 0.40 | Why? |
| Aspergillosis | 1 | 2013 | 264 | 0.39 | Why? |
| Glucosyltransferases | 2 | 2018 | 29 | 0.36 | Why? |
| Mutation | 6 | 2018 | 12376 | 0.33 | Why? |
| Dyspnea | 1 | 2020 | 3847 | 0.32 | Why? |
| Arrhythmias, Cardiac | 1 | 2020 | 2510 | 0.31 | Why? |
| Lung Transplantation | 4 | 2018 | 1554 | 0.31 | Why? |
| Electrocardiography | 1 | 2020 | 3957 | 0.30 | Why? |
| Referral and Consultation | 2 | 2018 | 4816 | 0.29 | Why? |
| Microbial Sensitivity Tests | 6 | 2020 | 2886 | 0.25 | Why? |
| Echinocandins | 4 | 2018 | 139 | 0.24 | Why? |
| Spain | 8 | 2020 | 15545 | 0.22 | Why? |
| Mycological Typing Techniques | 2 | 2018 | 38 | 0.22 | Why? |
| Fusariosis | 1 | 2020 | 14 | 0.21 | Why? |
| Percutaneous Coronary Intervention | 1 | 2017 | 3646 | 0.21 | Why? |
| Receptors, Epoprostenol | 1 | 2019 | 4 | 0.21 | Why? |
| Enzyme Activators | 1 | 2019 | 24 | 0.21 | Why? |
| Endothelin Receptor Antagonists | 1 | 2019 | 47 | 0.20 | Why? |
| Cryptococcus | 1 | 2019 | 29 | 0.20 | Why? |
| Invasive Pulmonary Aspergillosis | 2 | 2020 | 634 | 0.19 | Why? |
| Iloprost | 1 | 2018 | 38 | 0.19 | Why? |
| Phosphodiesterase 5 Inhibitors | 1 | 2019 | 104 | 0.19 | Why? |
| Heart Septum | 1 | 2018 | 29 | 0.18 | Why? |
| Heart-Lung Transplantation | 1 | 2017 | 39 | 0.18 | Why? |
| DNA Mutational Analysis | 2 | 2018 | 581 | 0.18 | Why? |
| Basidiomycota | 1 | 2018 | 42 | 0.18 | Why? |
| Acetates | 1 | 2019 | 123 | 0.18 | Why? |
| Cryptococcosis | 1 | 2019 | 97 | 0.17 | Why? |
| Surgical Wound | 1 | 2017 | 20 | 0.17 | Why? |
| Tricuspid Valve Insufficiency | 1 | 2018 | 94 | 0.17 | Why? |
| Diagnostic Techniques, Respiratory System | 1 | 2018 | 114 | 0.17 | Why? |
| Echocardiography, Doppler | 1 | 2019 | 269 | 0.17 | Why? |
| Endarterectomy | 1 | 2017 | 60 | 0.16 | Why? |
| Angina Pectoris | 1 | 2017 | 114 | 0.16 | Why? |
| Angiography | 1 | 2018 | 301 | 0.16 | Why? |
| Death, Sudden | 1 | 2018 | 160 | 0.16 | Why? |
| Diagnostic Techniques, Cardiovascular | 1 | 2018 | 144 | 0.16 | Why? |
| Walk Test | 1 | 2019 | 461 | 0.16 | Why? |
| Glycosides | 1 | 2017 | 94 | 0.16 | Why? |
| Voriconazole | 1 | 2018 | 206 | 0.16 | Why? |
| Hypertension | 1 | 2018 | 8895 | 0.15 | Why? |
| Pedigree | 1 | 2017 | 502 | 0.15 | Why? |
| Invasive Fungal Infections | 1 | 2020 | 274 | 0.15 | Why? |
| Chronic Disease | 3 | 2020 | 5139 | 0.15 | Why? |
| Carbamates | 1 | 2019 | 485 | 0.15 | Why? |
| Humans | 39 | 2021 | 930598 | 0.15 | Why? |
| Survival Rate | 3 | 2020 | 9206 | 0.15 | Why? |
| Connective Tissue Diseases | 1 | 2018 | 187 | 0.15 | Why? |
| Oxygen Inhalation Therapy | 2 | 2020 | 3629 | 0.15 | Why? |
| Age of Onset | 1 | 2017 | 557 | 0.14 | Why? |
| Lipopeptides | 2 | 2017 | 229 | 0.14 | Why? |
| Triterpenes | 1 | 2017 | 199 | 0.14 | Why? |
| Blood Culture | 1 | 2017 | 308 | 0.14 | Why? |
| Incidental Findings | 1 | 2019 | 487 | 0.14 | Why? |
| Catheter-Related Infections | 1 | 2018 | 381 | 0.13 | Why? |
| Blood Specimen Collection | 1 | 2018 | 387 | 0.13 | Why? |
| Coronavirus | 2 | 2020 | 18339 | 0.13 | Why? |
| Hematologic Neoplasms | 2 | 2018 | 2105 | 0.13 | Why? |
| Blood Chemical Analysis | 1 | 2018 | 541 | 0.13 | Why? |
| Male | 19 | 2020 | 367725 | 0.13 | Why? |
| Tubulin | 1 | 2013 | 67 | 0.13 | Why? |
| Hospitals, General | 1 | 2018 | 711 | 0.12 | Why? |
| False Positive Reactions | 1 | 2018 | 1338 | 0.12 | Why? |
| Adult | 16 | 2020 | 244371 | 0.12 | Why? |
| Fungal Proteins | 1 | 2013 | 133 | 0.12 | Why? |
| Metabolic Diseases | 1 | 2018 | 505 | 0.12 | Why? |
| Respiration Disorders | 1 | 2018 | 526 | 0.12 | Why? |
| Disease-Free Survival | 1 | 2017 | 1654 | 0.11 | Why? |
| Cluster Analysis | 2 | 2018 | 3001 | 0.11 | Why? |
| Female | 17 | 2020 | 380317 | 0.11 | Why? |
| Prognosis | 4 | 2020 | 32490 | 0.11 | Why? |
| Mycoses | 1 | 2018 | 589 | 0.11 | Why? |
| Cohort Studies | 3 | 2020 | 36005 | 0.11 | Why? |
| Scleroderma, Systemic | 1 | 2017 | 583 | 0.11 | Why? |
| Hospital Units | 1 | 2018 | 1017 | 0.11 | Why? |
| Kaplan-Meier Estimate | 2 | 2017 | 4260 | 0.11 | Why? |
| Aged | 13 | 2020 | 215776 | 0.10 | Why? |
| Middle Aged | 14 | 2020 | 270681 | 0.10 | Why? |
| Coronary Vessels | 1 | 2017 | 914 | 0.10 | Why? |
| Drug Monitoring | 1 | 2018 | 1408 | 0.10 | Why? |
| Disease Management | 2 | 2018 | 6841 | 0.10 | Why? |
| Fatal Outcome | 1 | 2019 | 3438 | 0.10 | Why? |
| Incidence | 3 | 2021 | 25622 | 0.10 | Why? |
| Combined Modality Therapy | 1 | 2018 | 3395 | 0.09 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.09 | Why? |
| Heart Defects, Congenital | 1 | 2018 | 933 | 0.09 | Why? |
| Tomography, X-Ray Computed | 3 | 2020 | 25144 | 0.09 | Why? |
| Genotype | 2 | 2018 | 4697 | 0.09 | Why? |
| Candidiasis | 3 | 2018 | 334 | 0.09 | Why? |
| Mucormycosis | 1 | 2017 | 832 | 0.09 | Why? |
| Drug Therapy, Combination | 2 | 2019 | 7268 | 0.08 | Why? |
| Treatment Outcome | 5 | 2020 | 51732 | 0.08 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.08 | Why? |
| Echocardiography | 1 | 2020 | 3661 | 0.08 | Why? |
| Asymptomatic Diseases | 1 | 2018 | 3444 | 0.08 | Why? |
| Young Adult | 5 | 2020 | 93724 | 0.07 | Why? |
| Neutropenia | 2 | 2020 | 388 | 0.07 | Why? |
| Hospitals, Teaching | 1 | 2013 | 1609 | 0.07 | Why? |
| Antihypertensive Agents | 1 | 2017 | 1962 | 0.07 | Why? |
| Evidence-Based Medicine | 1 | 2018 | 3228 | 0.07 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.06 | Why? |
| Prospective Studies | 5 | 2020 | 43301 | 0.06 | Why? |
| Cardiology | 1 | 2018 | 2873 | 0.06 | Why? |
| Magnetic Resonance Imaging | 1 | 2018 | 6551 | 0.06 | Why? |
| Registries | 2 | 2018 | 12327 | 0.06 | Why? |
| Heart Diseases | 1 | 2018 | 3503 | 0.05 | Why? |
| Algorithms | 1 | 2018 | 7346 | 0.05 | Why? |
| Soluble Guanylyl Cyclase | 1 | 2019 | 11 | 0.05 | Why? |
| Fusarium | 1 | 2020 | 44 | 0.05 | Why? |
| Sensitivity and Specificity | 1 | 2020 | 22971 | 0.05 | Why? |
| Lepidoptera | 1 | 2018 | 26 | 0.05 | Why? |
| Disk Diffusion Antimicrobial Tests | 1 | 2018 | 36 | 0.05 | Why? |
| Cunninghamella | 1 | 2017 | 9 | 0.04 | Why? |
| Cross Infection | 2 | 2018 | 8675 | 0.04 | Why? |
| Disease Progression | 1 | 2017 | 13580 | 0.04 | Why? |
| Rhizopus | 1 | 2017 | 32 | 0.04 | Why? |
| Genetic Variation | 1 | 2011 | 3919 | 0.04 | Why? |
| Heart Failure | 1 | 2018 | 6638 | 0.04 | Why? |
| Retrospective Studies | 5 | 2020 | 105322 | 0.04 | Why? |
| Microscopy, Electron, Scanning | 1 | 2017 | 221 | 0.04 | Why? |
| Candidiasis, Invasive | 1 | 2017 | 107 | 0.04 | Why? |
| Amphotericin B | 1 | 2017 | 256 | 0.04 | Why? |
| Follow-Up Studies | 3 | 2020 | 17020 | 0.04 | Why? |
| Forced Expiratory Volume | 1 | 2018 | 632 | 0.04 | Why? |
| Vasodilator Agents | 1 | 2018 | 344 | 0.04 | Why? |
| Chemoprevention | 1 | 2020 | 585 | 0.04 | Why? |
| Ventricular Function, Right | 1 | 2018 | 388 | 0.04 | Why? |
| Biomarkers | 1 | 2018 | 23361 | 0.03 | Why? |
| Chromatography, High Pressure Liquid | 1 | 2018 | 669 | 0.03 | Why? |
| Pandemics | 5 | 2021 | 389249 | 0.03 | Why? |
| Practice Guidelines as Topic | 1 | 2018 | 15421 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Risk Factors | 2 | 2020 | 71621 | 0.03 | Why? |
| Administration, Inhalation | 1 | 2018 | 1647 | 0.03 | Why? |
| DNA, Fungal | 1 | 2011 | 95 | 0.03 | Why? |
| Artifacts | 1 | 2013 | 250 | 0.03 | Why? |
| Molecular Typing | 1 | 2011 | 280 | 0.03 | Why? |
| Virulence | 1 | 2017 | 2172 | 0.03 | Why? |
| Dose-Response Relationship, Drug | 1 | 2018 | 3776 | 0.02 | Why? |
| Disease Outbreaks | 2 | 2020 | 27595 | 0.02 | Why? |
| Double-Blind Method | 1 | 2019 | 5988 | 0.02 | Why? |
| Aged, 80 and over | 1 | 2018 | 88759 | 0.02 | Why? |
| Environmental Microbiology | 1 | 2011 | 575 | 0.02 | Why? |
| Blood Pressure | 1 | 2017 | 2198 | 0.02 | Why? |
| Molecular Epidemiology | 1 | 2011 | 1638 | 0.02 | Why? |
| Survival Analysis | 1 | 2018 | 7592 | 0.02 | Why? |
| Cause of Death | 1 | 2018 | 4823 | 0.02 | Why? |
| Nursing Homes | 1 | 2020 | 4155 | 0.02 | Why? |
| Tertiary Care Centers | 1 | 2020 | 8248 | 0.01 | Why? |
| Logistic Models | 1 | 2017 | 9089 | 0.01 | Why? |
| Immunocompromised Host | 1 | 2018 | 5150 | 0.01 | Why? |
| Disease Models, Animal | 1 | 2018 | 10998 | 0.01 | Why? |
| Child | 2 | 2018 | 70012 | 0.01 | Why? |
| Anxiety | 1 | 2021 | 17311 | 0.01 | Why? |
| Time Factors | 1 | 2018 | 31397 | 0.01 | Why? |
| Child, Preschool | 1 | 2017 | 36283 | 0.01 | Why? |
| Hospital Mortality | 1 | 2017 | 22087 | 0.01 | Why? |
| Animals | 1 | 2018 | 78931 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2017 | 48226 | 0.01 | Why? |
| Adolescent | 1 | 2017 | 86841 | 0.00 | Why? |
Escribano Subías's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(186)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(82)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_